Responses

PDF

Heparin therapy in giant cell arteritis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Authors' Response
    • Lawrence M. Buono, Neuro-ophthalmology
    • Other Contributors:
      • Rod Foroozan, and Peter J. Savino

    Dear Editor

    We thank Dr Masood for his interest in our manuscript [1]. Clearly in some cases of giant cell arteritis (GCA), treatment with high dose corticosteroids alone is insufficient. The use of adjunctive heparin proved to be beneficial in our patient, although the reason is not clear [1]. Thrombocytosis has been shown to occur in a large percentage of patients with GCA [2, 3]. However, there is no convin...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Aspirin therapy for Giant Cell Arteritis

    Dear Editor

    I read with interest Buono et al's paper [1]. They describe in detail the value of anti-coagulant therapy in the management of giant cell arteritis. The role of anti-platelet agents however is not considered. It has been known for a number of years that thrombocytosis [2] and platelet hyper-reactivity [3] are features of giant cell arteritis. Experimental studies have shown that aspirin effectively sup...

    Show More
    Conflict of Interest:
    None declared.